H Pylori Recurrence After Successful Eradication
Overview
Authors
Affiliations
Recurrence of H pylori after eradication is rare in developed countries and more frequent in developing countries. Recrudescence (recolonization of the same strain within 12 mo after eradication) rather than reinfection (colonization with a new strain, more than 12 mo after eradication) is considered to be responsible for most of the cases. This observation was confirmed only in developed countries, while in developing countries a recent meta-analysis demonstrated a high rate of reinfection. The proportion of H pylori annual recurrence was 2.67% and 13.00% in developed and developing countries, respectively. Nested meta-analysis (only cases with a longer follow-up and a negative (13)CUBT a year after eradication) revealed annual recurrence rate of 1.45% [relative risk (RR), 0.54] and 12.00% (RR, 0.92) in developed and developing countries, respectively. These findings support the notion that in developed countries many cases of recurrence are due to recrudescence within the first year after eradication, with a 46% drop in the recurrence rate after the first year post eradication, while in developing countries reinfection is more pronounced, and continue at the same rate since eradication. A different approach for follow-up after H pylori eradication is probably needed in patients of developing countries, since reinfection is highly prevalent.
Urrutia-Baca V, Paz-Michel B, Calderon-Porras A, Valle J, Alvarez-Fernandez W, Mervitch-Sigal N Clin Exp Dent Res. 2024; 10(4):e927.
PMID: 38973212 PMC: 11228356. DOI: 10.1002/cre2.927.
Prevalence of Oral Infection in an Indigenous Community in Southwest Mexico.
Urrutia-Baca V, Gonzalez Brosig K, Salazar-Garza A, Gomez-Flores R, Tamez-Guerra P, De la Garza-Ramos M Clin Exp Gastroenterol. 2023; 16:173-180.
PMID: 37753185 PMC: 10519207. DOI: 10.2147/CEG.S424559.
Ning J, Fu W, Shi Y, Zhang J, Ding S Gut Pathog. 2023; 15(1):6.
PMID: 36782312 PMC: 9924195. DOI: 10.1186/s13099-023-00533-4.
Gut homeostasis, injury, and healing: New therapeutic targets.
Oncel S, Basson M World J Gastroenterol. 2022; 28(17):1725-1750.
PMID: 35633906 PMC: 9099196. DOI: 10.3748/wjg.v28.i17.1725.
Maiti K, Apolonski A Molecules. 2021; 26(11).
PMID: 34200454 PMC: 8201021. DOI: 10.3390/molecules26113474.